Medicare will now help pay for some GLP-1 drugs. Here’s what to know – CBS News Watch CBS News Starting Wednesday, Medicare will help pay for some GLP-1 medications for weight loss. CBS News medical correspondent Dr. Celine Gounder explains what this means for patients. Source link
Some Medicare patients will be able to access to GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more affordable. Called Medicare GLP-1 Bridge, the pilot program expands access to weight-loss drugs made by Eli Lilly and Novo … Read more
Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more. Source link
It’s that season again – the most uncovered time of the year. For some, swimsuits can be an issue, but not for Carly Anderson. The former elementary schoolteacher is now an online influencer, whose content celebrates people of all shapes, including her own. “Years and years ago, I started an online community called Just Wear … Read more
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The list of health benefits tied to the diabetes … Read more
Outspoken body acceptance advocate Katie Sturino, who is the founder of Megababe Beauty, explains why it was a difficult decision for her to start taking weight loss drugs. She’s joined by psychiatrist Dr. Sue Varma who breaks down what people should do before taking a GLP-1 and the impact of societal pressure. Source link
The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the approval of Novo Nordisk’s … Read more